If the thought of stopping or reducing GLP-1 medication causes significant anxiety, particularly if that anxiety is linked to fear of weight gain rather than concerns about your health condition, this is worth exploring with a specialist
Tirzepatide has a half-life of approximately five days, slightly shorter than semaglutide
Understanding their mechanisms, benefits, and associated risks will remain essential as their role in clinical medicine continues to expand
However, limited data are available regarding the effects of GLP-1 RAs on albuminuria status and kidney function in real-world settings, including populations with a lower baseline cardiovascular and kidney risk
Also, given that the studies don't prove that taking semaglutide raises your risk of developing NAION, its even harder to draw this conclusion, Dr